Cure My Disease

Don't miss your cure!

 Log in / Sign up

C-Section healing boost? trial tests simple adhesive strip trick

NCT ID NCT07686913

Disease control Sponsor: Riverside University Health System Medical Center Source: ClinicalTrials.gov ↗

What the study statuses mean

This study's is highlighted.

Recruitment status, easiest to join first

Recruiting now This study
This trial is taking on new participants right now.
Not yet recruiting
Registered, but not yet taking participants.
By invitation only
Not open to general applications. Only people the study team invites can take part.
Paused
Paused for now. It may or may not start again.
Ongoing
Running, but no longer taking on new participants.
Completed
The trial has finished. Results may not be published yet.
Stopped early
Stopped early, before it reached the end. That can be for many reasons, including safety.
Cancelled
Cancelled before anyone took part.

Expanded access (not trials)

Expanded access
Not a trial. This treatment can be requested outside a study, case by case, for people who qualify.
Expanded access (paused)
Not a trial. The treatment can normally be requested outside a study, but is unavailable right now.
Expanded access (ended)
Not a trial. The treatment could once be requested outside a study, but no longer can.
Approved
The treatment has been approved, so it is available normally rather than through this programme.

When the status isn't known

Details not published
The full record has not been published yet, so there is little to show here.
Status unknown
This status has not been confirmed recently, so it may be out of date.

First seen Jul 07, 2026 · Last updated Jul 08, 2026 · Updated 1 time

Summary

This trial tests whether adding Steri-Strips (adhesive strips) to standard wound closure after a cesarean section reduces complications like infection, fluid buildup, or wound reopening. About 610 women having a C-section will be randomly assigned to receive either standard closure plus Steri-Strips or standard closure alone. Researchers will compare wound healing, hospital stay length, readmissions, and costs to see if the strips are worth using routinely.

What this could mean

Our plain-language read of the trial. This is informational only, not medical advice or a prediction.

Active substance
Steri-Strip adhesive skin closure strips
What this could lead to
If Steri-Strips reduce wound complications, this could lead to a simple, low-cost change in how C-section incisions are closed, improving recovery for many women.
What could go wrong
Previous studies have shown mixed results, and Steri-Strips may increase costs, add surgical time, or cause skin irritation. This trial is not large enough to be definitive.

This is an AI summary of the original study and may miss details. Read our disclaimer.

Study facts

What this study's own registry entry says, in plain language.

Phase

Not a phased trial

Phase numbers describe drug development. The registry uses this when they do not apply, as it does for trials of devices, procedures or behaviour changes, and for observational studies.

Participants

About 610 people

The number the study aims to enrol. It can still change while the study runs.

Expected to start

Jun 2026

An estimate. Start dates often move.

Expected to finish

Dec 2027

An estimate. End dates often move.

Lead sponsor

Other sponsor

The registry's catch-all category, for sponsors it does not file as a company, a government agency, or a research network.

Who can take part

This study's own entry requirements. Only the study team can say for certain whether you qualify.

Ages

18 years and older

Sex

Female participants only

Healthy volunteers

Not accepted

This study is not open to healthy volunteers. The entry requirements below say who it is open to.

Show the full entry requirements

Copied word for word from the study's registry entry, so the wording is the study team's rather than ours.

Inclusion Criteria: * Female patients age 18 years or older * Pregnant patients undergoing cesarean delivery at Riverside University Health System Medical Center (RUHS) * Able and willing to provide informed consent Exclusion Criteria: * Known allergy or hypersensitivity to Steri-Strip™ materials or adhesives * Inability or unwillingness to provide informed consent * Anticipated inability to complete the 30-day postpartum follow-up evaluation

Get updates

Get notified about this study

Sign up to get updates when this study changes or when new studies for Cesarean section are added.

Our safety recommendation!

By submitting, you agree to our Terms of use

Conditions

The condition(s) this trial relates to.

Seroma Surgical Wound Infection

As listed by the trial registrant

The condition terms exactly as the trial's registrant entered them.

Cesarean section SEROMA Surgical site infection Wound dehiscence

How to take part

Only the study team decides who joins. These are the ways to reach them.

  1. The places running it

    1 site. The list below names each one and where it is.

  2. The official record

    ClinicalTrials.gov lists the study team's own contact details, including names and phone numbers. We don't republish those.

    Open the record ↗

  3. A doctor treating you

    A doctor who knows your case can contact a study site on your behalf, and can tell you whether this study is worth pursuing at all.

Contacts and locations

Locations

  • Riverside University Health System Medical Center

    RECRUITING

    Moreno Valley, California, 92555, United States

More trials for these conditions

Other studies related to the condition(s) this trial covers.